Market Cap (In INR)
205.4 Billion
Revenue (In INR)
61.12 Billion
Net Income (In INR)
6.15 Billion
Avg. Volume
485.32 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 746.0-1303.9
- PE
- -
- EPS
- -
- Beta Value
- 0.691
- ISIN
- INE901L01018
- CUSIP
- Y0R76F109
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Chirayu Ramanbhai Amin
- Employee Count
- -
- Website
- https://alembicpharmaceuticals.com
- Ipo Date
- 2011-09-20
- Details
- Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
More Stocks
-
RYR
-
SLMXFSlam Exploration Ltd.
SLMXF
-
EMEmak S.p.A.
EM
-
RAJKSYNRajkamal Synthetics Limited
RAJKSYN
-
PSDL
-
RVNL
-
CNMA
-
1900